Clinical Trial Update: A Comparison of AlloMap Molecular Testing and Traditional Biopsy-based Surveillance for Heart Transplant Rejection Early Post-transplantation [NA]

View source ↗

Summary

This clinical trial update compares AlloMap molecular testing with traditional biopsy-based surveillance for detecting heart transplant rejection early after tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplant Rejection

Snippet

Sponsor: XDx | Conditions: Graft Rejection, Heart Diseases | NA | Status: UNKNOWN